{
  "ticker": "EW",
  "year": 2025,
  "quarter": 1,
  "last_updated": "2025-04-19T10:04:54.704574",
  "count": 46,
  "transactions": [
    {
      "id": 323122,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-03-26",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 369799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-03-26",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 323191,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-03-13",
      "transaction_shares": "9500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "56435.7184"
    },
    {
      "id": 369870,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-03-13",
      "transaction_shares": "9500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "56435.7184"
    },
    {
      "id": 323179,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "400.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22988.0651"
    },
    {
      "id": 323188,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "7463.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "66545.9006"
    },
    {
      "id": 369857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "400.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22988.0651"
    },
    {
      "id": 369867,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "7463.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "66545.9006"
    },
    {
      "id": 279965,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-28",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 323126,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-28",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 369803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-28",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 280029,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "73.3000",
      "transaction_type": "F",
      "shares_after_transaction": "4684.1255"
    },
    {
      "id": 323193,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "73.3000",
      "transaction_type": "F",
      "shares_after_transaction": "4684.1255"
    },
    {
      "id": 369872,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "73.3000",
      "transaction_type": "F",
      "shares_after_transaction": "4684.1255"
    },
    {
      "id": 279973,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "30387.0000"
    },
    {
      "id": 279982,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-02-16",
      "transaction_shares": "333.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "198192.7390"
    },
    {
      "id": 280005,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-16",
      "transaction_shares": "214.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "22975.0651"
    },
    {
      "id": 323134,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "30387.0000"
    },
    {
      "id": 323143,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-02-16",
      "transaction_shares": "333.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "198192.7390"
    },
    {
      "id": 323166,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-16",
      "transaction_shares": "214.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "22975.0651"
    },
    {
      "id": 369811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "30387.0000"
    },
    {
      "id": 369820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-02-16",
      "transaction_shares": "333.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "198192.7390"
    },
    {
      "id": 369844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-16",
      "transaction_shares": "214.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "22975.0651"
    },
    {
      "id": 279989,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-14",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 323150,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-14",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 369827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-14",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 279963,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-02-13",
      "transaction_shares": "6500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "53435.7184"
    },
    {
      "id": 279993,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-13",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "35774.0000"
    },
    {
      "id": 280003,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-13",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 280016,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-13",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 323124,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-02-13",
      "transaction_shares": "6500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "53435.7184"
    },
    {
      "id": 323154,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-13",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "35774.0000"
    },
    {
      "id": 323164,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-13",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 323177,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-13",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 369801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-02-13",
      "transaction_shares": "6500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "53435.7184"
    },
    {
      "id": 369832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-13",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "35774.0000"
    },
    {
      "id": 369842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-13",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 369855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-13",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 242225,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242256,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 280012,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280045,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 323173,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323209,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 369851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369888,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    }
  ]
}